RBOT
Vicarious Surgical Inc.
NYSE: RBOT · HEALTHCARE · MEDICAL DEVICES
$0.50
-9.09% today
Updated 2026-04-30
Market cap
$3.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.19
Dividend yield
—
52W range
$0 – $14
Volume
0.1M
Vicarious Surgical Inc. (RBOT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.71M | $-12.04M | $-33.30M | $-61.21M | $-62.30M | $-49.96M | $-45.08M |
| Capital expenditures | $246000.00 | $120000.00 | $1.29M | $5.35M | $1.67M | $180000.00 | $132000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $337000.00 | $448000.00 | $3.69M | $12.26M | $13.27M | $11.90M | $8.13M |
| Free cash flow | $-8.96M | $-12.16M | $-34.59M | $-66.56M | $-63.98M | $-50.14M | $-45.21M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-57.42M | — | — | — |